Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00651261 Information provided by National Cancer Institute (NCI)

First Received: April 1, 2008 Last Updated: October 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)